|An infant with mild blepharitis on his right side|
Blepharitis is one of the most common ocular conditions characterized by inflammation, scaling, reddening, and crusting of the eyelid. This condition may also cause swelling, burning, itching, or a grainy sensation when introducing foreign objects or substances to the eye. Although blepharitis by itself is not sight-threatening, it can lead to permanent alterations of the eyelid margin. The primary cause is bacteria and inflammation from congested meibomian oil glands at the base of each eyelash. Other conditions may give rise to blepharitis, whether they be infectious or noninfectious, including, but not limited to, bacterial infections or allergies.
Different variations of blepharitis can be classified as seborrheic, staphylococcal, mixed, posterior or meibomitis, or parasitic. In a survey of US ophthalmologists and optometrists, 37% to 47% of patients seen by those surveyed had signs of blepharitis, which can affect all ages and ethnic groups. One single-center study of 90 patients with chronic blepharitis found that the average age of patients was 50 years old. The word is from Greek: βλέφαρον / blepharon, eyelid and -itis, inflammation of.
Signs and symptoms
Blepharitis is characterized by chronic inflammation of the eyelid, usually at the base of the eyelashes. Symptoms include inflammation, irritation, itchiness, a burning sensation, excessive tearing, and crusting and sticking of eyelids. Additional symptoms may include visual impairment such as photophobia and blurred vision. Symptoms are generally worse in the mornings and patients may experience exacerbation and several remissions if left untreated. It is typically caused by bacterial infection or blockage of the meibomian oil glands. Diseases and conditions that may lead to blepharitis include: rosacea, herpes simplex dermatitis, varicella-zoster dermatitis, molluscum contagiosum, allergic dermatitis, contact dermatitis, seborrheic dermatitis, staphylococcal dermatitis, demodicosis (Demodex), and parasitic infections (e.g., Demodex and Phthiriasis palpebrarum).
The parasite Demodex folliculorum (D. folliculorum) causes blepharitis when the parasite is present in excessive numbers within the dermis of the eyelids. These parasites can live for approximately 15 days. The parasites (both adult and eggs) live on the hair follicle, inhabiting the sebaceous and apocrine gland of the human lid. Direct contact allows this pathogen to spread. Factors that allow this pathogen to multiply include hypervascular tissue, poor hygienic conditions, and immune deficiency. In treating blepharitis caused by D. folliculorum, mechanical cleaning and proper hygiene are important towards decreasing the parasite's numbers. 
- Watery eyes – due to excessive tearing.
- Red eyes – due to dilated blood vessels on the sclera.
- Swollen eyelids – due to inflammation.
- Crusting at the eyelid margins/base of the eyelashes/medial canthus, generally worse on waking – due to excessive bacterial buildup along the lid margins.
- Eyelid sticking – due to crusting along the eyelid margin.
- Eyelid itching – due to the irritation from inflammation and epidermis scaling of the eyelid.
- Flaking of skin on eyelids – due to tear film suppressed by clogged meibomian glands.
- Gritty/burning sensation in the eye, or foreign-body sensation – due to crusting from bacteria and clogged oil glands
- Frequent blinking – due to impaired tear film from clogged oil glands unable to keep tears from evaporating.
- Light sensitivity/photophobia
- Misdirected eyelashes that grow abnormally – due to permanent damage to the eyelid margin
- Eyelash loss – due to excessive buildup of bacteria along the base of the eyelashes.
- Infection of the eyelash follicle/sebaceous gland (hordeolum)
- Debris in the tear film, seen under magnification (improved contrast with use of fluorescein drops)
Chronic blepharitis may result in damage of varying severity and, in the worst cases, may have a negative effect on vision. This can be resolved with a proper eyeglass prescription. Long-term untreated blepharitis can lead to eyelid scarring, excess tearing, difficulty wearing contact lenses, development of a stye (an infection near the base of the eyelashes, resulting in a painful lump on the edge of the eyelid) or a chalazion (a blockage/bacteria infection in a small oil glands at the margin of the eyelid, just behind the eyelashes, leading to a red, swollen eyelid), chronic pink eye (conjunctivitis), keratitis, and corneal ulcer or irritation. The lids may become red and may have ulcerate, non-healing areas that may lead to bleeding. Blepharitis can also cause blurred vision due to a poor tear film. Tears may be frothy or bubbly, which can contribute to mild scarring along the eyelids. Symptoms and signs of blepharitis are often erroneously ascribed by the patient as "recurrent conjunctivitis".
General symptoms include a foreign body sensation, matting of the lashes, and burning. Collarette around eyelashes, a ring-like formation around the lash shaft, can be observed. Other symptoms include loss of eyelashes or broken eyelashes. The condition can sometimes lead to a chalazion or a stye. Chronic bacterial blepharitis may also lead to ectropion. Posterior blepharitis or rosacea-associated blepharitis is manifested by a broad spectrum of symptoms involving the lids including inflammation and plugging of the meibomian orifices and production of abnormal secretion upon pressure over the glands.
The mechanism by which the bacteria causes symptoms of blepharitis is not fully understood and may include direct irritation of bacterial toxins and/or enhanced cell-mediated immunity to S. aureus.
Staphylococcal blepharitis is caused by an infection of the anterior portion of the eyelid by Staphylococcal bacteria. In a study of ocular flora, 46% to 51% of those diagnosed with staphylococcal blepharitis had cultures positive for Staphylococcus aureus in comparison to 8% of normal patients. Staphylococcal blepharitis may start in childhood and continue into adulthood. It is commonly recurrent and it requires special medical care. The prevalence of Staphylococcus aureus in the conjunctival sac and on the lid margin varies among countries, likely due to differences in climate and environment. Seborrheic blepharitis is characterized by less inflammation than Staphylococcal blepharitis; however, it causes more excess oil or greasy scaling. Meibomian gland dysfunction is a result of abnormalities of the meibomian glands and altered secretion of meibum, which plays an imperative role in lagging the evaporation of tear films and smoothing of the tear film to produce an even optical surface. Posterior blepharitis is an inflammation of the eyelids, secondary to dysfunction of the meibomian glands. Like anterior blepharitis, it is a bilateral chronic condition and may be associated with skin rosacea. There is growing evidence that, in some cases, it is caused by demodex mites.
In all forms of blepharitis, optometrists or ophthalmologists examine the tear film, which is the most efficient method in determining instability. The most frequently used method is to measure tear production via tear break-up time (TBUT), which calculates the duration interval between complete blinks. This serves as a primary indication of regional dryness in the pre-corneal tear film after fluorescein injections. If TBUT is shorter than 10 seconds, then this suggests instability.
Staphylococcal blepharitis is diagnosed by examining erythema and edema of the eyelid margin. Patients may exhibit alopecia areata of eyelashes and/or growth misdirection, trichiasis. Other signs may include telangiectasia on the anterior eyelid, collarettes encircling the lash base, and corneal changes. Seborrheic blepharitis is distinguished by less erythema, edema, and telangiectasia of the eyelid margins. Posterior blepharitis and Meibomian gland dysfunction are frequently associated with rosacea and can be seen during an ocular examination of the posterior eyelid margin. The Meibomian glands may appear caked with oil or visibly obstructed.
Cultures of the eyelid margins can be a clear indicator for patients who have recurrent anterior blepharitis with severe inflammation, in addition to patients who are not responding to therapy. Measurements of tear osmolarity may be beneficial in diagnosing concurrent dry eye syndrome (DES), which may be responsible for overlapping symptoms and would allow the physician to decipher between conditions and move forward with the most beneficial protocol for the patient. Consequently, the measurement of tear osmolarity has various limitations in differentiating between aqueous deficiencies and evaporative dry eye. Microscopic evaluation of epilated eyelashes may reveal mites, which have been evident in cases of chronic blepharoconjunctivitis. A biopsy of the eyelid can also determine the exclusion of carcinoma, therapy resistance, or unifocal recurrent chalazia.
|Bacterial infections||Erysipelas (due to Streptococcus pyogenes)
Impetigo (due to Staphylococcus aureus)
|Viral infections||Herpes simplex virus|
|Parasitic infection||Pediculosis palperbrarum|
|Immunologic conditions||Atopic dermatitis|
|Benign eyelid tumors||Actinic keratosis|
|Malignant eyelid tumors||Melanoma|
Blepharitis is a result of bacteria and inflammation from congested meibomian oil glands at the base of each eyelash. Routine washing of the eyelids helps subdue symptoms and prevent blepharitis. Washing each eyelid for 30 seconds, twice a day, with a single drop of hypoallergenic soap (e.g. baby shampoo) and ample water can help. The most effective treatment is over the counter lid scrubs used twice a day. Some doctors may recommend using a hypochlorous acid treatment depending on the severity.
Blepharitis is a chronic condition causing frequent exacerbation, thus requiring routine eyelid hygiene. Hygienic practices include warm compresses, eyelid massages, and eyelid scrubs. A Cochrane Systematic Review found topical antibiotics to be effective in providing help symptomatic relief and clearing bacteria for individuals with anterior blepharitis. Topical steroids provided some symptomatic relief, but they were ineffective in clearing bacteria from the eyelids. Lid hygiene measures such as warm compresses and lid scrubs were found to be effective in providing symptomatic relief for participants with anterior and posterior blepharitis.
There is inadequate evidence to draw conclusions about the use of oral doxycycline in the treatment of blepharitis. According to very low certainty data, oral doxycycline may help with symptoms like itchiness, burning, or watery eyes, but may induce more side effects.
Blepharitis is a chronic condition that has periods of exacerbation and remission. Patients should be informed that symptoms can frequently improve but are rarely eliminated. Infrequently, severe blepharitis can result in permanent alterations in the eyelid margin or vision loss from superficial keratopathy, corneal neovascularization, and ulceration. Patients with an inflammatory eyelid lesion that appears suspicious of malignancy should be referred to an appropriate specialist.
A study conducted in November 2017 detected a correlation between blepharitis and early-onset metabolic syndrome (MetS). To investigate the relationship between blepharitis and MetS, researchers used the Longitudinal Health Insurance Database in Taiwan. Results indicated that hyperlipidaemia and coronary artery disease were significantly correlated with the prior development of blepharitis. Therefore, blepharitis was shown to be significantly related to MetS and can serve as an early indication of the condition.
In another study, the presence of Demodex mites was shown to be a common cause of blepharitis. However, the pathogenesis of demodicosis is still unclear. In this study, researchers provided a diagnosis of the disease and proposed diagnostic criteria for Demodex blepharitis.
- Cunningham ET, Riordan-Eva P (2011-05-17). Vaughan & Asbury's general ophthalmology (18th ed.). McGraw-Hill Medical. ISBN 978-0071634205.
- Singh Tonk R, Hossain K (November 27, 2014). "Blepharitis". EyeWiki. American Academy of Ophthalmology.
- "Blepharitis Definition - Diseases and Conditions". Mayo Clinic.
- "Blepharitis: Symptoms, Treatment, and Prevention". WebMD, LLC.
- Lowery RS (3 January 2019). Law SK, Rapuano CJ (eds.). "Adult Blepharitis". Medscape.
- Inceboz T, Yaman A, Over L, Ozturk AT, Akisu C (2009). "Diagnosis and treatment of demodectic blepharitis". Turkiye Parazitolojii Dergisi. 33 (1): 32–36. PMID 19367544.
- "Blepharitis Symptoms - Diseases and Conditions". Mayo Clinic.
- Weinstock FJ. "Eyelid Inflammation Symptoms". emedicinehealth.com. Retrieved 21 December 2012.
- "Blepharitis Complications - Diseases and Conditions". Mayo Clinic.
- Dahl A. "What are the symptoms and signs of blepharitis?". medicinenet.com. Retrieved 21 December 2012.
- Garrity J (August 2012). "Blepharitis". The Merck Manual. Retrieved 21 December 2012.
- "Blepharitis, Stye and Chalazion". University of Illinois College of Medicine. Archived from the original on 19 April 2014. Retrieved 21 December 2012.
- Heiting G (January 2019). "How to Get Rid of Sore, Red Eyelids (Blepharitis)". All About Vision.
- Biggers A (29 March 2017). "Staphylococcal Blepharitis". Healthline.
- "Blepharitis". Angeles Vision Clinic. Archived from the original on 4 May 2012. Retrieved 21 December 2012.
- Smolin G, Okumoto M (May 1977). "Staphylococcal blepharitis". Archives of Ophthalmology. 95 (5): 812–816. doi:10.1001/archopht.1977.04450050090009. PMID 324453.
- Liu J, Sheha H, Tseng SC (October 2010). "Pathogenic role of Demodex mites in blepharitis". Current Opinion in Allergy and Clinical Immunology. 10 (5): 505–510. doi:10.1097/aci.0b013e32833df9f4. PMC 2946818. PMID 20689407.
- "Blepharitis Tests and diagnosis - Diseases and Conditions". Mayo Clinic.
- Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E (March 2008). "The challenge of dry eye diagnosis". Clinical Ophthalmology. 2 (1): 31–55. doi:10.2147/opth.s1496. PMC 2698717. PMID 19668387.
- Nemoto Y, Arita R, Mizota A, Sasajima Y (September 2014). "Differentiation between chalazion and sebaceous carcinoma by noninvasive meibography". Clinical Ophthalmology. 8: 1869–1875. doi:10.2147/OPTH.S69804. PMC 4172083. PMID 25258508.
- Lindsley K, Matsumura S, Hatef E, Akpek EK (May 2012). "Interventions for chronic blepharitis". The Cochrane Database of Systematic Reviews. 5 (5): CD005556. doi:10.1002/14651858.CD005556.pub2. PMC 4270370. PMID 22592706.
- Onghanseng N, Ng SM, Halim MS, Nguyen QD, et al. (Cochrane Eyes and Vision Group) (June 2021). "Oral antibiotics for chronic blepharitis". The Cochrane Database of Systematic Reviews. 2021 (6): CD013697. doi:10.1002/14651858.CD013697.pub2. PMC 8189606. PMID 34107053.
- Navel V, Mulliez A, Benoist d'Azy C, Baker JS, Malecaze J, Chiambaretta F, Dutheil F (October 2019). "Efficacy of treatments for Demodex blepharitis: A systematic review and meta-analysis". The Ocular Surface. 17 (4): 655–669. doi:10.1016/j.jtos.2019.06.004. PMID 31229586.
- "Blepharitis Treatments and drugs - Diseases and Conditions". Mayo Clinic.
- Dahl AA. "Blepharitis". MedicineNet.
- Lee CY, Chen HC, Lin HW, Huang JY, Chao SC, Yeh CB, et al. (September 2018). "Blepharitis as an early sign of metabolic syndrome: a nationwide population-based study". The British Journal of Ophthalmology. 102 (9): 1283–1287. doi:10.1136/bjophthalmol-2017-310975. PMID 29146760. S2CID 26261977.
- Liang LY, Li J, Liu Y (September 2017). "[Diagnostic criteria of demodex blepharitis]". [Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology. 53 (9): 648–652. doi:10.3760/cma.j.issn.0412-4081.2017.09.003. PMID 28926882.
- blepharitis Resource Guide from the National Eye Institute (NEI).
- eMedicine Health: Eyelid Inflammation (blepharitis)